Unicharm (OTCMKTS:UNICY) Short Interest Up 487.5% in July

Unicharm (OTCMKTS:UNICY - Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 4,700 shares, anincreaseof487.5% from the June 30th total of 800 shares. Based on an average trading volume of 1,146,100 shares, the days-to-cover ratio is currently 0.0 days. Based on an average trading volume of 1,146,100 shares, the days-to-cover ratio is currently 0.0 days.Unicharm Price PerformanceUNICY opened at $3.56 on Friday. The company has a fifty day moving average price of $3.70 and a two-hundred day moving average price of $3.96. The firm has a market capitalization of $12.48 billion, a PE ratio of 17.80 and a beta of 0.22. Unicharm has a 52 week low of $3.06 and a 52 week high of $8.10. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.86 and a current ratio of 2.31. Unicharm (OTCMKTS:UNICY - Get Free Report) last posted its quarterly earnings results on Friday, May 9th. The company reported $0.05 earnings per share (EPS) for the quarter. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.69 billion. As a group, analysts anticipate that Unicharm will post 0.17 earnings per share for the current year. Unicharm Company Profile (Get Free Report)Unicharm Corporation engages in the manufacturing and sale of wellness, feminine, baby and children, kirei, and pet care products in Japan and internationally. The company's baby and child care products, including disposable diapers and wipes under the Moony, MamyPoko, Oyasumiman, and Torepanman brands; feminine care products comprise napkins, tampons, panty liners, sanitary short, panty liners, and other feminine care products under the Sofy, Center-In, and Unicharm brand names; and wellness care products include napkin-type incontinence pads, pants-type diapers, tape-type diapers, pants-type specialized urine pads, and tape-type specialized urine pads under the Lifree and Charmnap brand.Recommended StoriesFive stocks we like better than UnicharmMastering Discipline: Overcoming Emotional Challenges In TradingWill Hims & Hers Fall Along With Novo Nordisk?Best of the list of Dividend Aristocrats: Build wealth with the aristocrat indexPlay It Cool: Why Comfort Systems USA Is a Hidden AI Winner3 Stocks to Protect Your Portfolio from the Coronavirus Contagion Rocket Lab Reports Next Week: Here’s What Investors Should KnowThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Unicharm Right Now?Before you consider Unicharm, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Unicharm wasn't on the list.While Unicharm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here